GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivo Bio Tech Ltd (BOM:511509) » Definitions » Gross Margin %

Vivo Bio Tech (BOM:511509) Gross Margin % : 91.38% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vivo Bio Tech Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Vivo Bio Tech's Gross Profit for the three months ended in Mar. 2024 was ₹107.4 Mil. Vivo Bio Tech's Revenue for the three months ended in Mar. 2024 was ₹117.6 Mil. Therefore, Vivo Bio Tech's Gross Margin % for the quarter that ended in Mar. 2024 was 91.38%.


The historical rank and industry rank for Vivo Bio Tech's Gross Margin % or its related term are showing as below:

BOM:511509' s Gross Margin % Range Over the Past 10 Years
Min: 69.22   Med: 81.19   Max: 91.53
Current: 91.53


During the past 13 years, the highest Gross Margin % of Vivo Bio Tech was 91.53%. The lowest was 69.22%. And the median was 81.19%.

BOM:511509's Gross Margin % is ranked better than
87.55% of 747 companies
in the Biotechnology industry
Industry Median: 60.9 vs BOM:511509: 91.53

Vivo Bio Tech had a gross margin of 91.38% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Vivo Bio Tech was 2.10% per year.


Vivo Bio Tech Gross Margin % Historical Data

The historical data trend for Vivo Bio Tech's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivo Bio Tech Gross Margin % Chart

Vivo Bio Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.54 86.08 77.74 87.04 91.53

Vivo Bio Tech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.39 84.86 98.90 92.37 91.38

Competitive Comparison of Vivo Bio Tech's Gross Margin %

For the Biotechnology subindustry, Vivo Bio Tech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivo Bio Tech's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's Gross Margin % falls into.



Vivo Bio Tech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Vivo Bio Tech's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=416 / 454.512
=(Revenue - Cost of Goods Sold) / Revenue
=(454.512 - 38.497) / 454.512
=91.53 %

Vivo Bio Tech's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=107.4 / 117.583
=(Revenue - Cost of Goods Sold) / Revenue
=(117.583 - 10.136) / 117.583
=91.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vivo Bio Tech  (BOM:511509) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vivo Bio Tech had a gross margin of 91.38% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Vivo Bio Tech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Vivo Bio Tech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivo Bio Tech (BOM:511509) Business Description

Traded in Other Exchanges
N/A
Address
Number 8-2-672/ 5 and 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.

Vivo Bio Tech (BOM:511509) Headlines

No Headlines